Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P170027/S020

TherOx Downstream System

Zoll Circulation, Inc. · Decision date Oct 29, 2025

FDA DECISIONP170027/S020

What did the FDA decide?

FDA records P170027/S020 as a supplement to PMA P170027, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 29, 2025.

FDA approval order statement

approval of cleaning solution change for TherOx DownStream Cartridge Components due to current solution obsolescence
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 29, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P170027/S020
Regulatory pathway
PMA supplement
Product code
MWG
Decision code
OK30
Decision date
Oct 29, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, oxygen, aqueous.

Product code
MWG
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P170027/S020 received

    Application receipt date recorded by FDA.

  2. P170027/S020 · FDA decision

    30-Day Notice

  3. P170027/S018 · Related supplement

    TherOx Downstream System

Timeline entries are records held by MedtechLedger for P170027. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P170027

Product / regulatory recordCompanyPathwayDecision dateSource
Zoll Circulation, Inc.PMA supplementApr 10, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Zoll Circulation, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
2000 Ringwood Ave., San Jose, CA, 95131

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records